Skip Nav Destination
Issues
March 2017
ISSN 2296-5270
EISSN 2296-5262
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2017, Vol. 40, No. 3
Editorial Board / Contents / Imprint
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 73–78.
https://doi.org/10.1159/000464146
Editorial
HIV-Associated Malignancies
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 80–81.
https://doi.org/10.1159/000456716
Review Article
HIV-Associated Malignant Lymphoma
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 82–87.
https://doi.org/10.1159/000456036
HIV-Associated Lung Cancer
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 88–92.
https://doi.org/10.1159/000458442
HIV-Associated Kaposi's Sarcoma
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 94–98.
https://doi.org/10.1159/000455971
HIV-Associated Anal Dysplasia and Anal Carcinoma
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 100–105.
https://doi.org/10.1159/000456715
HIV-Associated Urogenital Malignancies
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 106–112.
https://doi.org/10.1159/000457130
Erratum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 114.
https://doi.org/10.1159/000463742
Review Article
HIV-Associated Gastrointestinal Cancer
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 115–118.
https://doi.org/10.1159/000456714
Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 120–127.
https://doi.org/10.1159/000458443
Original Article
Increased Expression of miR-29a and Its Prognostic Significance in Patients with Cholangiocarcinoma
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 128–132.
https://doi.org/10.1159/000455869
Novel Insights from Clinical Practice
Long-Term Relief of Cerebral Radiation Necrosis Treated with Low-Dose Bevacizumab - a Report of 2 Cases
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 133–137.
https://doi.org/10.1159/000455868
Letter to the Editor
Prophylaxis and Treatment of Cancer-Associated Venous Thromboembolism - Comparison Hematologist/ Oncologists versus Angiologist/Phlebologists
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 138–140.
https://doi.org/10.1159/000456670
Reports of Oncological Societies
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 141–148.
https://doi.org/10.1159/000463522
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 149.
https://doi.org/10.1159/000464150
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 150–151.
https://doi.org/10.1159/000464151
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 152–153.
https://doi.org/10.1159/000464152
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 155.
https://doi.org/10.1159/000464153
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 156.
https://doi.org/10.1159/000464154
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 157–160.
https://doi.org/10.1159/000464155
Meetings and Conferences
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (3): 162–163.
https://doi.org/10.1159/000463520
